Physician profile
Matthew D Perry
NPI 1669670675
$15,786.12
in general payments reported to CMS, 2019-2025
19 companies · $296 in 2025
The $296 reported for 2025 was more than what 75% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $53.30 · 2021: $345 · 2022: $3,253 · 2023: $732 · 2024: $327 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748 · Consulting Fee: $600 · Education: $6.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.19 |
| Consulting Fee | $600.00 |
| Education | $6.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $9,047.96 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $5,416.78 | 2019-2024 | Eliquis, Camzyos |
| Ethicon US, LLC | $378.29 | 2021-2025 | Evarrest, Ethicon, Dermabond |
| Astrazeneca Pharmaceuticals LP | $201.94 | 2022-2024 | Andexxa |
| Csl Behring | $177.96 | 2019-2024 | Kcentra |
| Stryker Corporation | $168.36 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Inari Medical, INC. | $51.30 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ucb, INC. | $38.26 | 2024 | Briviact |
| Aesculap, INC. | $29.75 | 2025 | Aesculap Ff399r Adaptor |
| Ceribell, INC. | $25.00 | 2025 | Pocket Eeg Device |
| Purdue Pharma L.P. | $23.88 | 2024 | Nalmefene Hydrochloride |
| Integra Lifesciences Corporation | $20.02 | 2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Janssen Pharmaceuticals, INC | $16.27 | 2020 | |
| Bioxcel Therapeutics, INC. | $14.87 | 2023 | Igalmi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clinical Technology, INC | $13.80 | 2024 | Vascular Product |
| Gilead Sciences, INC. | $12.81 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.01 | 2019 | |
| Medical Device Business Services, INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.